Drug intelligence / Profile preview

tetraxetan

Development stage
Unknown
Lead developer
Grupo Juste
Modality
Small Molecules
Administration
Intravenous
01

Overview

Tetraxetan, also known as DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), is a macrocyclic chelating agent produced as an active pharmaceutical ingredient (API) by Laboratorios Juste. It is a small molecule designed to sequester metal ions, such as gadolinium, gallium, and lutetium, within its 12-membered tetraaza ring and four acetic acid arms. This chelation process creates highly stable, non-toxic complexes suitable for medical use. Tetraxetan is a fundamental component in the production of gadoteric acid, a macrocyclic contrast agent used in magnetic resonance imaging (MRI). Additionally, it is a cornerstone of the radiopharmaceutical industry, where it acts as a bifunctional chelator conjugated to peptides or antibodies to deliver radionuclides for diagnostic PET/SPECT imaging or targeted radionuclide therapy in oncology.

Other names
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acidDOTA

Beyond the preview

Go deeper on tetraxetan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetraxetan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call